메뉴 건너뛰기
Lupus
Volumn 22, Issue 5, 2013, Pages 541-542
Factors associated with blood hydroxychloroquine level in lupus patients: Renal function could be important
Author keywords

[No Author keywords available]
Indexed keywords

HYDROXYCHLOROQUINE;
EID: 84875962563     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313476361     Document Type: Letter
Times cited : (30)
References (7)
  • 1
    • 6844255888 scopus 로고    scopus 로고
    • A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group
    • Tsakonas E, Joseph L, Esdaile JM, et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus. 1998 ; 7: 80-85
    • (1998) Lupus , vol.7 , pp. 80-85
    • Tsakonas, E.1    Joseph, L.2    Esdaile, J.M.3
  • 2
    • 65649142017 scopus 로고    scopus 로고
    • A new equation to estimate glomerular filtration rate
    • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 ; 150: 604-612
    • (2009) Ann Intern Med , vol.150 , pp. 604-612
    • Levey, A.S.1    Stevens, L.A.2    Schmid, C.H.3
  • 3
    • 33750302628 scopus 로고    scopus 로고
    • Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
    • Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 3284-3290
    • (2006) Arthritis Rheum , vol.54 , pp. 3284-3290
    • Costedoat-Chalumeau, N.1    Amoura, Z.2    Hulot, J.S.3
  • 4
    • 84885183319 scopus 로고    scopus 로고
    • Hydroxychloroquine in systemic lupus erythematosus: Results of a French multicentre controlled trial (PLUS Study)
    • Costedoat-Chalumeau N, Galicier L, Aumaitre O, et al. Hydroxychloroquine in systemic lupus erythematosus: Results of a French multicentre controlled trial (PLUS Study). Ann Rheum Dis. 2012 ; Nov 10 :
    • (2012) Ann Rheum Dis , vol.10
    • Costedoat-Chalumeau, N.1    Galicier, L.2    Aumaitre, O.3
  • 5
    • 0029951024 scopus 로고    scopus 로고
    • Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
    • Furst DE. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lupus. 1996 ; 5 Suppl 1: S11-5
    • (1996) Lupus , vol.51 , pp. 11-5
    • Furst, D.E.1
  • 6
    • 0026545115 scopus 로고
    • Ocular safety of hydroxychloroquine sulfate (Plaquenil)
    • Bernstein HN. Ocular safety of hydroxychloroquine sulfate (Plaquenil). South Med J. 1992 ; 85: 274-279
    • (1992) South Med J , vol.85 , pp. 274-279
    • Bernstein, H.N.1
  • 7
    • 0033673147 scopus 로고    scopus 로고
    • Hydroxychloroquine neuromyotoxicity
    • Stein M, Bell MJ, Ang LC. Hydroxychloroquine neuromyotoxicity. J Rheumatol. 2000 ; 27: 2927-2931
    • (2000) J Rheumatol , vol.27 , pp. 2927-2931
    • Stein, M.1    Bell, M.J.2    Ang, L.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.